Percutaneous coronary intervention as an alternative to bypass surgery for unprotected LMCA stenosis

Expert Review of Cardiovascular Therapy

Volumn 6, Issue 8, 2008, Pages 1107-1114

  Park, Seung Jung ^a   Kim, Young Hak ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Bypass surgery; Left main; Prognosis; Restenosis; Stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN; THIENOPYRIDINE DERIVATIVE;

ANGIOCARDIOGRAPHY; ANGIOGRAPHY; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; DRUG SAFETY; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; LEFT MAIN CORONARY ARTERY STENOSIS; LOADING DRUG DOSE; LONG TERM CARE; MORTALITY; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; RESTENOSIS; REVIEW; SURGICAL RISK; SURVIVAL RATE; THROMBOSIS; TREATMENT REFUSAL;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; HUMANS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 55349092682     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.6.8.1107     Document Type: Review

References (39)

1. Park SJ. Left Main Stem Disease. Informa Healthcare, Seoul, South Korea (2006).
2. Park SJ, Kim YH, Lee BK et al. Sirolimuseluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J. Am. Coll. Cardiol. 45 (3), 351-356 (2005).
3. Chieffo A, Stankovic G, Bonizzoni E et al. Early and mid-term results of drug-eluting scent implantation in unprotected left main. Circulation 111 (6), 791-795 (2005).
4. Valgimigh M, van Mieghem CA, Ong AT et al. Short- and long-term clinical outcome after drug-cluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the rapamycineluting and taxus stent evaluated at Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation 111(11), 1383-1389 (2005).
5. Price MJ, Cristea E, Sawhney N et al. Serial angiographic follow-up of sirolimuseluting stents for unprotected left main coronary artery revascularization. J. Am. Coll. Cardiol. 47(4), 871-877 (2006).
6. Palmerini T, Marzocchi A, Marrozzini C et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am. J. Cardiol. 98(1), 54-59 (2006).
7. Lee MS, Kapoor N, Jamal F et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J. Am. Coll. Cardiol. 47(4), 864-870 (2006).
8. Buszman PE, Kiesz SR, Bochenek A et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J. Am. Coll. Cardiol. 51(5), 538-545 (2008).
9. Kim YH, Dangas GD, Solinas E et al. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. Am. J. Cardiol. 101(6), 801-806 (2008).
10. Seung KB, Park DW, Kim YH et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N. Engl. J. Med. 358(17), 1781-1792 (2008).
11. de Lezo JS, Medina A, Pan M et al. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. Am. Heart J. 1480), 481-485 (2004).
12. Chieffo A, Morici N, Maisano F et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a singlecenter experience. Circulation 113(21), 2542-2547 (2006).
13. Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (17), 2126-2130 (2005).
14. Stone GW, Moses JW, Ellis SG et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N. Engl. J. Med. 356(10), 998-1008 (2007).
15. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Scent thrombosis in randomized clinical trials of drug-eluting stents. N. Engl. J. Med. 356(10), 1020-1029 (2007).
16. Kuchulakanti PK, Cbu WW, Torguson R et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113(8), 1108-1113 (2006).
17. Farb A, Boam AB. Scent thrombosis redux - the FDA perspective. N. Engl. J. Med. 356(10), 984-987 (2007).
18. Marroquin OC, Selzer F, Mulukutla SR et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N. Engl. J. Med. 358(4), 342-352 (2008).
19. TU JV, Bowen J, Chiu M et al. Effectiveness and safety of drug-eluting stents in Ontario. N. Engl. J. Med. 357(14), 1393-1402 (2007).
20. Walters DL, Harding SA, Walsh CR, Wong P, Pomerantsev E, Jang IK. Acute coronary syndrome is a common clinical presentation of in-stent restenosis. Am. J. Cardiol. 89(5), 491-494 (2002).
21. Nayak AK, Kawamura A, Nesto RW et al. Myocardial infarction as a presentation of clinical in-stent restenosis. Circ. J. 70 (8), 1026-1029 (2006).
22. Takagi T, Stankovic G, Finci L et al. Results and long-term predictors of adverse clinical events after elective percutancous interventions on unprotected left main coronary artery. Circulation 106(6), 698-702 (2002).
23. Biondi-Zoccai GGL, Lotrionte M, Moretti C et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am. Heart J. 155 (2), 274-283 (2008).
24. Tan WA, Tamai H, Park SJ et al. Longterm clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation 104(14), 1609-1614 (2001).
25. Valgimigli M, Malagutti P, Rodriguez-Granillo GA et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Scent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. J. Am. Coll. Cardiol. 47(8), 1530-1537 (2006).
26. Kim YH, Ahn JM, Park DW et al. EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am. J. Cardiol. 98(12), 1567-1570 (2006).
27. Baierl V, Baumgartner S, Pollinger B et al. Three-year clinical follow-up after strontium-90/yttrium-90 β-irradiation for the treatment of in-stent coronary restenosis. Am. J. Cardiol. 96(10), 1399-1403 (2005).
28. Chieffo A, Park SJ, Valgimigli M et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery. A multicenter registry. Circulation 116(2), 158-162 (2007).
29. Valgimigh M, Malagutti P, Rodriguez Granillo GA et al. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries. Am. Heart J. 152 (5), 896-902 (2006).
30. Kim YH, Park SW, Hong MK et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am. J. Cardiol. 97(11), 1597-1601 (2006).
31. Park SJ, Park SW, Hong MK et al. Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. J. Am. Coll. Cardiol. 31(1), 37-42 (1998).
32. Costa MA, Gigliotti OS, Zenni MM, Gilmore PS, Bass TA. Synergistic use of sirolimus-eluting stents and intravascular ultrasound for the treatment of unprotected left main and vein graft disease. Catheter Cardiovasc. Interv. 61(3), 368-375 (2004).
33. Das P, Meredith I. Role of intravascular ultrasound in unprotected left main percutaneous coronary intervention. Expert Rev. Cardiovasc. Ther. 5(1), 81-89 (2007).
34. Agostoni P, Valgimigli M, Van Mieghem CAG et al. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am. J. Cardiol. 95 (5), 644-647 (2005).
35. Mintz GS, Weissman NJ. intravascular ultrasound in the drug-eluting stent era. J. Am. Coll. Cardiol. 48(3), 421-429 (2006).
36. Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/SCAI Writing Committee to update 2001 guidelines for percutaneous coronary intervention). Circulation 113(7), e166-e286 (2006).
37. Takaro T, Huttgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation 54(6 Suppl.), III107-III117 (1976).
38. Chairman BR, Fisher LD, Bourassa MG et al. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am. J. Cardiol. 48 (4), 765-777 (1981).
39. Ong ATL, Serruys PW, Mohr FW et al. The Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) study: design, rationale, and run-in phase. Am. Heart J. 151(6), 1194-1204 (2006).